Beone Medicines Ltd (ONC) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Beone Medicines Ltd   (NASDAQ: ONC)

Beone Medicines Ltd Profitability Comparisons

Select each Category to receive further Information




ONC Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 88.96 % 70.86 % 67.38 % 46.15 %
Gross Margin (Q1 TTM) 88.33 % 71.39 % 67.8 % 46.36 %
Gross Profit Margin 5 Yr. Avg. 84.45 % 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q1 MRQ) 19.85 % 21.18 % 18.45 % 20.46 %
EBITDA Margin (Q1 TTM) 14.36 % 25.13 % 20.78 % 20.1 %
EBITDA Margin 5 Yr. Avg. --54.92 % 47.09 % 31.38 % 23.39 %
Operating Margin (Q1 MRQ) 16.51 % 17.04 % 16.52 % 16.05 %
Operating Margin (Q1 TTM) 11.95 % 20.45 % 17.83 % 16.34 %
Operating Margin 5 Yr. Avg. --60.88 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q1 MRQ) 17.13 % 13.42 % 10.72 % 13.96 %
Pre-Tax Profit Margin (Q1 TTM) 11.42 % 16.68 % 12.68 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q1 MRQ) 15.02 % 9.91 % 8.02 % 11.42 %
Net Margin (Q1 TTM) 8.94 % 13.16 % 9.86 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Product revenue
  Explore Product revenue Segment  -
Product revenue BRUKINSA
  Explore Product revenue BRUKINSA Segment  -
Product revenue TEVIMBRA
  Explore Product revenue TEVIMBRA Segment  -
Product revenue XGEVA
  Explore Product revenue XGEVA Segment  -
Product revenue BLINCYTO
  Explore Product revenue BLINCYTO Segment  -
Product revenue KYPROLIS
  Explore Product revenue KYPROLIS Segment  -
Product revenue POBEVCY
  Explore Product revenue POBEVCY Segment  -
Product revenue Other
  Explore Product revenue Other Segment  -
U S - total revenue
  Explore U S - total revenue Segment  -
China - total revenue
  Explore China - total revenue Segment  -
Europe - total revenue
  Explore Europe - total revenue Segment  -
Rest of world - total revenue
  Explore Rest of world - total revenue Segment  -
Product revenue U S - total revenue
  Explore Product revenue U S - total revenue Segment  -
Product revenue China - total revenue
  Explore Product revenue China - total revenue Segment  -
Product revenue Europe - total revenue
  Explore Product revenue Europe - total revenue Segment  -
Product revenue Rest of world - total revenue
  Explore Product revenue Rest of world - total revenue Segment  -
Other Revenue
  Explore Other Revenue Segment  -
Other Revenue Novartis
  Explore Other Revenue Novartis Segment  -
Amgen royalty revenue Novartis
  Explore Amgen royalty revenue Novartis Segment  -
Novartis broad markets revenue Novartis
  Explore Novartis broad markets revenue Novartis Segment  -
Other Novartis
  Explore Other Novartis Segment  -
Other Revenue U S - total revenue
  Explore Other Revenue U S - total revenue Segment  -
Other Revenue China - total revenue
  Explore Other Revenue China - total revenue Segment  -
Other Revenue Europe - total revenue
  Explore Other Revenue Europe - total revenue Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) 10.61 % -0.01 % 0.22 % 1.39 %
Free Cash Flow Margin (Q1 TTM) 19.08 % 17.47 % 13.83 % 9.08 %
Free Cash Flow Margin 5 Yr. Avg. - 19.28 % 14.86 % 15.58 %
Net Cash Flow Margin (Q1 MRQ) 16.11 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) 40.48 % -0.36 % 0.15 % 1.85 %
Net Cash Flow Margin 5 Yr. Avg. - 4.38 % 3.16 % 6.44 %
Effective Tax Rate (Q1 MRQ) 12.29 % 25.94 % 25.04 % 18.8 %
Effective Tax Rate (Q1 TTM) 21.7 % 21.36 % 23 % 19.44 %
Effective Tax Rate 5 Yr. Avg. - 15.08 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.